Investigations of ocular side effects of topically applied 0.002% EYBELIS

Investigations of ocular side effects of topically applied 0.002% EYBELIS - Investigations of ocular side effects of topically applied 0.002% EYBELIS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039592

Enrollment

Registered

2020-03-07

Start date

2018-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Primary open angle glaucoma without any other ocular complications

Exclusion criteria

Exclusion criteria: Pathologies associate with ocular inflammation such as diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Measure the aqueous flare by means of laser-flare metry	—

Secondary

Measure	Time frame
Measure the intraocular pressure by means of tonometry	—

Countries

Japan

Contacts

Public ContactKensaku Miyake

Shohzankai Medical Foundation Miyake Eye Hospital Director

miyake@spice.or.jp052-915-8001

Outcome results